Sfoglia per Autore
Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient.
2011-01-01 Alonci, Andrea; Penna, G; Allegra, Alessandro; D'Angelo, A; Gangemi, Sebastiano; Ferraro, M; Spatari, Giovanna; Bacci, F; Gerace, D; Musolino, Caterina
Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera.
2011-01-01 Allegra A; Alonci A; Bellomo G; Campo S; Cannavò A; Penna G; Russo S; Centorrino R; Gerace D; Petrungaro A; Musolino C.
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients.
2011-01-01 Musolino, Caterina; Alonci, Andrea; Allegra, Alessandro; Saija, Antonina; Penna, G; Cannavò, A; Cristani, Mariateresa; Saitta, Salvatore; Gangemi, Sebastiano
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia
2012-01-01 Musolino, Caterina; Allegra, Alessandro; Saija, Antonina; Alonci, Andrea; Russo, Sabina; Spatari, Giovanna; Penna, Giuseppa; Gerace, DEMETRIO GABRIELE; Cristani, Mariateresa; David, Antonio; Saitta, Salvatore; Gangemi, Sebastiano
Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602.
2012-01-01 Penna, G; Allegra, Alessandro; Romeo, G; Alonci, Andrea; Cannavò, A; Russo, S; D'Angelo, A; Petrungaro, A; Musolino, Caterina
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review).
2012-01-01 Allegra, Alessandro; Alonci, Andrea; Campo, Salvatore Giuseppe; Penna, Giuseppa; Petrungaro, Annamaria; Gerace, DEMETRIO GABRIELE; Musolino, Caterina
Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission.
2012-01-01 Alonci A; Allegra A; Russo S; Penna G; Bellomo G; D'Angelo A; Campo S; Cannavò A; Centorrino R; Musolino C.
Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions.
2012-01-01 Gangemi, Sebastiano; Allegra, Alessandro; Alonci, Andrea; Cristani, Mariateresa; Russo, S; Speciale, Antonio; Penna, Giuseppa; Spatari, Giovanna; Cannavò, A; Bellomo, G; Musolino, Caterina
Relationship between Advanced oxidation protein products, Advanced glycation end products and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-Chronic Lymphocytic Leukemia.
2012-01-01 Gangemi, Sebastiano; Allegra, Alessandro; Aguennouz, M'Hammed; Alonci, Andrea; Speciale, Antonio; Cannavò, A.; Cristani, Mariateresa; Russo, S.; Spatari, Giovanna; Alibrandi, Angela; Musolino, Caterina
Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia.
2012-01-01 Gangemi, Sebastiano; Allegra, Alessandro; Pace, E.; Alonci, Andrea; Ferraro, M.; Petrungaro, A.; Saitta, S.; Gerace, D.; Russo, S.; Penna, G.; Musolino, Caterina
Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options.
2012-01-01 Allegra, Alessandro; Alonci, Andrea; Penna, G; Russo, S; Gerace, D; Greve, B; D'Angelo, A; Catena, S; Musolino, Caterina
Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients.
2012-01-01 Musolino, Caterina; Allegra, Alessandro; Ferraro, MARIA GRAZIA; Aguennouz, M'Hammed; Russo, S.; Alonci, Andrea; Saitta, Salvatore; Gangemi, Sebastiano
Reduction in IL–33 plasma levels might be involved in T–cell dysregulation in chronic lymphocytic leukemia.
2013-01-01 Allegra, Alessandro; Gangemi, Sebastiano; Profita, M; Alonci, Andrea; Saitta, S; Petrungaro, A; Bonanno, A; Gerace, D; Calabrò, A; Musolino, Caterina
Increased serum levels of interleukin-31 could modulate inflammatory processes in multiple sclerosis
2013-01-01 Gangemi, Sebastiano; Allegra, Alessandro; Mannucci, Carmen; Alonci, Andrea; Calapai, F.; Musolino, Caterina
Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
2013-01-01 Musolino, Caterina; Allegra, Alessandro; Profita, M; Alonci, Andrea; Saitta, S; Russo, S; Bonanno, A; Innao, Vanessa; Gangemi, Sebastiano
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia.
2013-01-01 Gangemi, Sebastiano; Allegra, Alessandro; Profita, M.; Saitta, Salvatore; Gerace, DEMETRIO GABRIELE; Bonanno, A.; Alonci, Andrea; Petrungaro, A. M.; Russo, S.; Musolino, Caterina
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.
2013-01-01 Allegra A; Penna G; Alonci A; Russo S; Greve B; Innao V; Minardi V; Musolino C.
Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia
2013-01-01 Gangemi, Sebastiano; Allegra, Alessandro; Alonci, Andrea; Pace, E; Cannavò, A; Ferraro, M; Penna, G; Saitta, Salvatore; Gerace, DEMETRIO GABRIELE; Musolino, Caterina
Reduction in IL-33 Plasma Levels Might Be Involved in T Cell Dysregulation in Chronic Lymphocytic Leukemia.
2013-01-01 Musolino, Caterina; Allegra, Alessandro; Profita, M; Alonci, Andrea; Saitta, Salvatore; Bonanno, A; Gerace, DEMETRIO GABRIELE; Calabrò, L; Gangemi, Sebastiano
New orally active proteasome inhibitors in multiple myeloma.
2014-01-01 Allegra A; Alonci A; Gerace D; Russo S; Innao V; Calabrò L; Musolino C.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient. | 1-gen-2011 | Alonci, Andrea; Penna, G; Allegra, Alessandro; D'Angelo, A; Gangemi, Sebastiano; Ferraro, M; Spatari, Giovanna; Bacci, F; Gerace, D; Musolino, Caterina | |
Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera. | 1-gen-2011 | Allegra A; Alonci A; Bellomo G; Campo S; Cannavò A; Penna G; Russo S; Centorrino R; Gerace D; Petrungaro A; Musolino C. | |
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. | 1-gen-2011 | Musolino, Caterina; Alonci, Andrea; Allegra, Alessandro; Saija, Antonina; Penna, G; Cannavò, A; Cristani, Mariateresa; Saitta, Salvatore; Gangemi, Sebastiano | |
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia | 1-gen-2012 | Musolino, Caterina; Allegra, Alessandro; Saija, Antonina; Alonci, Andrea; Russo, Sabina; Spatari, Giovanna; Penna, Giuseppa; Gerace, DEMETRIO GABRIELE; Cristani, Mariateresa; David, Antonio; Saitta, Salvatore; Gangemi, Sebastiano | |
Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602. | 1-gen-2012 | Penna, G; Allegra, Alessandro; Romeo, G; Alonci, Andrea; Cannavò, A; Russo, S; D'Angelo, A; Petrungaro, A; Musolino, Caterina | |
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). | 1-gen-2012 | Allegra, Alessandro; Alonci, Andrea; Campo, Salvatore Giuseppe; Penna, Giuseppa; Petrungaro, Annamaria; Gerace, DEMETRIO GABRIELE; Musolino, Caterina | |
Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission. | 1-gen-2012 | Alonci A; Allegra A; Russo S; Penna G; Bellomo G; D'Angelo A; Campo S; Cannavò A; Centorrino R; Musolino C. | |
Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions. | 1-gen-2012 | Gangemi, Sebastiano; Allegra, Alessandro; Alonci, Andrea; Cristani, Mariateresa; Russo, S; Speciale, Antonio; Penna, Giuseppa; Spatari, Giovanna; Cannavò, A; Bellomo, G; Musolino, Caterina | |
Relationship between Advanced oxidation protein products, Advanced glycation end products and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-Chronic Lymphocytic Leukemia. | 1-gen-2012 | Gangemi, Sebastiano; Allegra, Alessandro; Aguennouz, M'Hammed; Alonci, Andrea; Speciale, Antonio; Cannavò, A.; Cristani, Mariateresa; Russo, S.; Spatari, Giovanna; Alibrandi, Angela; Musolino, Caterina | |
Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia. | 1-gen-2012 | Gangemi, Sebastiano; Allegra, Alessandro; Pace, E.; Alonci, Andrea; Ferraro, M.; Petrungaro, A.; Saitta, S.; Gerace, D.; Russo, S.; Penna, G.; Musolino, Caterina | |
Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options. | 1-gen-2012 | Allegra, Alessandro; Alonci, Andrea; Penna, G; Russo, S; Gerace, D; Greve, B; D'Angelo, A; Catena, S; Musolino, Caterina | |
Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients. | 1-gen-2012 | Musolino, Caterina; Allegra, Alessandro; Ferraro, MARIA GRAZIA; Aguennouz, M'Hammed; Russo, S.; Alonci, Andrea; Saitta, Salvatore; Gangemi, Sebastiano | |
Reduction in IL–33 plasma levels might be involved in T–cell dysregulation in chronic lymphocytic leukemia. | 1-gen-2013 | Allegra, Alessandro; Gangemi, Sebastiano; Profita, M; Alonci, Andrea; Saitta, S; Petrungaro, A; Bonanno, A; Gerace, D; Calabrò, A; Musolino, Caterina | |
Increased serum levels of interleukin-31 could modulate inflammatory processes in multiple sclerosis | 1-gen-2013 | Gangemi, Sebastiano; Allegra, Alessandro; Mannucci, Carmen; Alonci, Andrea; Calapai, F.; Musolino, Caterina | |
Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease | 1-gen-2013 | Musolino, Caterina; Allegra, Alessandro; Profita, M; Alonci, Andrea; Saitta, S; Russo, S; Bonanno, A; Innao, Vanessa; Gangemi, Sebastiano | |
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. | 1-gen-2013 | Gangemi, Sebastiano; Allegra, Alessandro; Profita, M.; Saitta, Salvatore; Gerace, DEMETRIO GABRIELE; Bonanno, A.; Alonci, Andrea; Petrungaro, A. M.; Russo, S.; Musolino, Caterina | |
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma. | 1-gen-2013 | Allegra A; Penna G; Alonci A; Russo S; Greve B; Innao V; Minardi V; Musolino C. | |
Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia | 1-gen-2013 | Gangemi, Sebastiano; Allegra, Alessandro; Alonci, Andrea; Pace, E; Cannavò, A; Ferraro, M; Penna, G; Saitta, Salvatore; Gerace, DEMETRIO GABRIELE; Musolino, Caterina | |
Reduction in IL-33 Plasma Levels Might Be Involved in T Cell Dysregulation in Chronic Lymphocytic Leukemia. | 1-gen-2013 | Musolino, Caterina; Allegra, Alessandro; Profita, M; Alonci, Andrea; Saitta, Salvatore; Bonanno, A; Gerace, DEMETRIO GABRIELE; Calabrò, L; Gangemi, Sebastiano | |
New orally active proteasome inhibitors in multiple myeloma. | 1-gen-2014 | Allegra A; Alonci A; Gerace D; Russo S; Innao V; Calabrò L; Musolino C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile